Re-injected stems cells in rats' hearts can replenish damaged regions of their hearts and repair them, new research suggests.
Bald men have a higher risk of developing heart disease than men with a full head of hair, a new study suggests.
Researchers say taking calcium supplements nearly doubles your risk of having a heart attack. But is the research actually any good?
Jeremy Pearson, Associate Medical Director at the British Heart Foundation has told ITV News that a new study claiming that cholesterol-lowering drugs can also help healthy people could be helpful, but would not suggest "medicalising the whole country".
More than a third of people prescribed drugs for high cholesterol are putting themselves at a dramatically increased risk of heart problems by failing to take their medication for the condition, the British Heart Foundation (BHF) has warned.
The BHF said online research into 1,025 people in the UK conducted in February has shown 36% of cholesterol patients fail to take their prescribed medication for the condition.
The research has coincided with a study that also found cholesterol-lowering drugs could benefit even apparently healthy people with no previous history of heart disease.
UK experts have said more affordable ways of identifying patients suitable for statin therapy were needed, after a recent study found that the treatment could benefit even healthy people with no history of heart disease.
In an accompanying article, Professor Shah Ebrahim and Dr Juan Casas from the London School of Hygiene and Tropical Medicine wrote:
"Because most people older than 50 years are likely to be at a greater than 10% 10-year risk of CVD (cardio-vascular disease), it would be more pragmatic to use age as the only indicator of statin prescription. This approach would avoid the costs".
Cholesterol-lowering drugs can benefit even apparently healthy people with no previous history of heart disease, a study has found.
The authors of the new research say the findings suggest international treatment guidelines for statins should be reconsidered.
– Professor Colin Baigent, from Oxford University
This benefit greatly exceeds any known hazards of statin therapy. Under present guidelines, such individuals would not typically be regarded as suitable for [low density lipoprotein] LDL-lowering statin therapy.
The present report suggests, therefore, that these guidelines might need to be reconsidered.
A study has found Statins reduced the risk of serious vascular events by more than a fifth for each unit reduction in levels of harmful cholesterol. In individuals where the five-year chance of a major event was less than 10%, the already small risk was significantly lowered.
''This large-scale research found even people at low risk of heart disease could benefit from statin therapy''
– June Davison, senior cardiac nurse at the British Heart Foundation
''The findings will help to inform policy and treatment guidelines in the future''
A study has found Cholesterol-lowering drugs can benefit even apparently healthy people with no previous history of heart disease.
Experts say the findings suggest everyone over a certain age should qualify for statin therapy.
Many doctors already take the pills, which lower levels of cholesterol in the blood.
But NHS prescriptions of the drugs are restricted to patients judged to have at least a 20% risk of a "major vascular event" in the next 10 years.